A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
Titel:
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
Auteur:
Tryfonidis, Konstantinos Basaran, Gul Bogaerts, Jan Debled, Marc Dirix, Luc Thery, Jean-Christophe Tjan-Heijnen, Vivianne C.G. Van den Weyngaert, Danielle Cufer, Tanja Piccart, Martine Cameron, David